These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 33338425)

  • 1. DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor Immunity.
    Lu C; Guan J; Lu S; Jin Q; Rousseau B; Lu T; Stephens D; Zhang H; Zhu J; Yang M; Ren Z; Liang Y; Liu Z; Han C; Liu L; Cao X; Zhang A; Qiao J; Batten K; Chen M; Castrillon DH; Wang T; Li B; Diaz LA; Li GM; Fu YX
    Cancer Cell; 2021 Jan; 39(1):96-108.e6. PubMed ID: 33338425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLH1 Deficiency-Triggered DNA Hyperexcision by Exonuclease 1 Activates the cGAS-STING Pathway.
    Guan J; Lu C; Jin Q; Lu H; Chen X; Tian L; Zhang Y; Ortega J; Zhang J; Siteni S; Chen M; Gu L; Shay JW; Davis AJ; Chen ZJ; Fu YX; Li GM
    Cancer Cell; 2021 Jan; 39(1):109-121.e5. PubMed ID: 33338427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of tumor cell-intrinsic STING signaling are associated with increased infiltration of CD8
    Kanoda R; Nakajima S; Fukai S; Saito M; Saito K; Suzuki H; Kikuchi T; Nirei A; Okayama H; Mimura K; Hanayama H; Sakamoto W; Momma T; Saze Z; Kono K
    Sci Rep; 2024 Sep; 14(1):20859. PubMed ID: 39242811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the cGAS-STING pathway in regulating the tumor-immune microenvironment in dMMR/MSI colorectal cancer.
    Kaneta A; Nakajima S; Okayama H; Matsumoto T; Saito K; Kikuchi T; Endo E; Ito M; Mimura K; Kanke Y; Saito M; Saze Z; Fujita S; Sakamoto W; Onozawa H; Momma T; Ohki S; Kono K
    Cancer Immunol Immunother; 2022 Nov; 71(11):2765-2776. PubMed ID: 35429245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity.
    Lim J; Rodriguez R; Williams K; Silva J; Gutierrez AG; Tyler P; Baharom F; Sun T; Lin E; Martin S; Kayser BD; Johnston RJ; Mellman I; Delamarre L; West NR; Müller S; Qu Y; Heger K
    Cancer Immunol Res; 2024 Jun; 12(6):663-672. PubMed ID: 38489753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.
    Germano G; Lamba S; Rospo G; Barault L; Magrì A; Maione F; Russo M; Crisafulli G; Bartolini A; Lerda G; Siravegna G; Mussolin B; Frapolli R; Montone M; Morano F; de Braud F; Amirouchene-Angelozzi N; Marsoni S; D'Incalci M; Orlandi A; Giraudo E; Sartore-Bianchi A; Siena S; Pietrantonio F; Di Nicolantonio F; Bardelli A
    Nature; 2017 Dec; 552(7683):116-120. PubMed ID: 29186113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING-IFN-β pathway.
    Takahashi M; Lio CJ; Campeau A; Steger M; Ay F; Mann M; Gonzalez DJ; Jain M; Sharma S
    Nat Immunol; 2021 Apr; 22(4):485-496. PubMed ID: 33767426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of the cGAS-STING Pathway in dMMR/MSI-H in Colorectal Cancer].
    Kaneta A; Nakajima S; Mimura K; Kono K
    Gan To Kagaku Ryoho; 2022 Oct; 49(10):1130-1132. PubMed ID: 36281609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zebularine elevates STING expression and enhances cGAMP cancer immunotherapy in mice.
    Lai J; Fu Y; Tian S; Huang S; Luo X; Lin L; Zhang X; Wang H; Lin Z; Zhao H; Lin S; Zhao J; Xu S; Li D; Cai S; Dong L; Qian J; Liang J; Li Q; Zhang Y; Fan J; Balderas R; Chen Q
    Mol Ther; 2021 May; 29(5):1758-1771. PubMed ID: 33571681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN-driven CCL5 and CXCL10.
    Mowat C; Mosley SR; Namdar A; Schiller D; Baker K
    J Exp Med; 2021 Sep; 218(9):. PubMed ID: 34297038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Potential of a Novel Therapeutic Strategy for Colorectal Cancer Targeting the cGAS-STING Pathway].
    Nakajima S; Kaneta A; Kono K
    Gan To Kagaku Ryoho; 2023 Sep; 50(9):950-954. PubMed ID: 37800285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cGAS-STING cytosolic DNA sensing pathway is suppressed by JAK2-STAT3 in tumor cells.
    Suter MA; Tan NY; Thiam CH; Khatoo M; MacAry PA; Angeli V; Gasser S; Zhang YL
    Sci Rep; 2021 Mar; 11(1):7243. PubMed ID: 33790360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
    Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
    Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting MUS81 promotes the anticancer effect of WEE1 inhibitor and immune checkpoint blocking combination therapy via activating cGAS/STING signaling in gastric cancer cells.
    Li C; Shen Q; Zhang P; Wang T; Liu W; Li R; Ma X; Zeng X; Yin Y; Tao K
    J Exp Clin Cancer Res; 2021 Oct; 40(1):315. PubMed ID: 34625086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.
    Anghelina D; Lam E; Falck-Pedersen E
    J Virol; 2016 Jul; 90(13):5915-27. PubMed ID: 27076643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS/STING activation.
    Hu M; Zhou M; Bao X; Pan D; Jiao M; Liu X; Li F; Li CY
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33290271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors.
    Wang L; Yang L; Wang C; Zhao W; Ju Z; Zhang W; Shen J; Peng Y; An C; Luu YT; Song S; Yap TA; Ajani JA; Mills GB; Shen X; Peng G
    J Clin Invest; 2020 Nov; 130(11):5951-5966. PubMed ID: 33016929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of genomic and immune responses during primary immunotherapy resistance in mismatch repair-deficient tumors.
    Takahashi N; Rajapakse VN; Pongor L; Kumar S; Tlemsani C; Erwin-Cohen R; Young HA; Hewitt S; Wei JS; Khan J; Villarino AV; Trepel JB; Thomas A
    Cold Spring Harb Mol Case Stud; 2020 Oct; 6(5):. PubMed ID: 33028646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baculovirus Transduction in Mammalian Cells Is Affected by the Production of Type I and III Interferons, Which Is Mediated Mainly by the cGAS-STING Pathway.
    Amalfi S; Molina GN; Bevacqua RJ; López MG; Taboga O; Alfonso V
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.